Refractory Transformed Indolent Non-Hodgkin Lymphoma
1 clinical trials · Condition
◉ Watch Refractory Transformed Indolent Non-Hodgkin Lymphoma
| Record | Firm | Date |
|---|---|---|
| Venetoclax, Carmustine, Etoposide, Cytarabine, and Melphalan Before Stem Cell Transplant in Treating Participants With Relapsed or Refractory Non-Hodgkin Lymphoma (NCT03583424) | Ohio State University Comprehensive Cancer Center | 2018-09-10 |
Track Refractory Transformed Indolent Non-Hodgkin Lymphoma automatically
Every clearance here is in the API, with alerts when new ones post.